Department of Gastroenterology, Hepatology and Digestive Oncology, Erasme University Hospital Université Libre de Bruxelles, Brussels, Belgium.
Gedyt Endoscopy Center, Buenos Aires, Argentina.
Endoscopy. 2018 May;50(5):524-546. doi: 10.1055/a-0588-5365. Epub 2018 Apr 9.
1: ESGE suggests using contrast-enhanced computed tomography (CT) as the first-line imaging modality on admission when indicated and up to the 4th week from onset in the absence of contraindications. Magnetic resonance imaging (MRI) may be used instead of CT in patients with contraindications to contrast-enhanced CT, and after the 4th week from onset when invasive intervention is considered because the contents (liquid vs. solid) of pancreatic collections are better characterized by MRI and evaluation of pancreatic duct integrity is possible. Weak recommendation, low quality evidence. 2: ESGE recommends against routine percutaneous fine needle aspiration (FNA) of (peri)pancreatic collections. Strong recommendation, moderate quality evidence. FNA should be performed only if there is suspicion of infection and clinical/imaging signs are unclear. Weak recommendation, low quality evidence. 3: ESGE recommends initial goal-directed intravenous fluid therapy with Ringer's lactate (e. g. 5 - 10 mL/kg/h) at onset. Fluid requirements should be patient-tailored and reassessed at frequent intervals. Strong recommendation, moderate quality evidence. 4: ESGE recommends against antibiotic or probiotic prophylaxis of infectious complications in acute necrotizing pancreatitis. Strong recommendation, high quality evidence. 5: ESGE recommends invasive intervention for patients with acute necrotizing pancreatitis and clinically suspected or proven infected necrosis. Strong recommendation, low quality evidence.ESGE suggests that the first intervention for infected necrosis should be delayed for 4 weeks if tolerated by the patient. Weak recommendation, low quality evidence. 6: ESGE recommends performing endoscopic or percutaneous drainage of (suspected) infected walled-off necrosis as the first interventional method, taking into account the location of the walled-off necrosis and local expertise. Strong recommendation, moderate quality evidence. 7: ESGE suggests that, in the absence of improvement following endoscopic transmural drainage of walled-off necrosis, endoscopic necrosectomy or minimally invasive surgery (if percutaneous drainage has already been performed) is to be preferred over open surgery as the next therapeutic step, taking into account the location of the walled-off necrosis and local expertise. Weak recommendation, low quality evidence. 8: ESGE recommends long-term indwelling of transluminal plastic stents in patients with disconnected pancreatic duct syndrome. Strong recommendation, low quality evidence. Lumen-apposing metal stents should be retrieved within 4 weeks to avoid stent-related adverse effects.Strong recommendation, low quality evidence.
1: ESGE 建议在有指征的情况下,在发病后 4 周内使用增强 CT 作为入院时的一线影像学检查方法,如果没有禁忌症的话。如果有增强 CT 的禁忌症,或者在发病 4 周后需要进行有创介入治疗,可以使用磁共振成像(MRI)代替 CT,因为 MRI 可以更好地描述胰腺积液的内容物(液体与固体),并且可以评估胰管的完整性。弱推荐,低质量证据。
2: ESGE 不建议常规进行经皮细针抽吸(FNA)术以抽吸(胰周)胰腺积液。强烈推荐,中等质量证据。只有在怀疑感染且临床/影像学征象不明确时,才应进行 FNA。弱推荐,低质量证据。
3: ESGE 建议在发病时开始进行目标导向的静脉内乳酸林格氏液(例如,5-10ml/kg/h)治疗。液体需求应根据患者情况量身定制,并频繁重新评估。强烈推荐,中等质量证据。
4: ESGE 不建议预防性使用抗生素或益生菌预防急性坏死性胰腺炎的感染性并发症。强烈推荐,高质量证据。
5: ESGE 建议对患有急性坏死性胰腺炎且临床怀疑或确诊感染性坏死的患者进行有创干预。强烈推荐,低质量证据。ESGE 建议如果患者能够耐受,感染性坏死的首次干预应延迟 4 周。弱推荐,低质量证据。
6: ESGE 建议根据胰腺假性囊肿的位置和当地专业知识,选择内镜或经皮引流(疑似)感染性隔离坏死作为首选介入方法。强烈推荐,中等质量证据。
7: ESGE 建议,如果内镜经壁引流隔离性坏死后没有改善,在考虑隔离性坏死位置和当地专业知识的情况下,应优先选择内镜坏死切除术或微创外科手术(如果已经进行了经皮引流)作为下一步治疗措施,而不是开放性手术。弱推荐,低质量证据。
8: ESGE 建议在断开的胰管综合征患者中长期留置经腔塑料支架。强烈推荐,低质量证据。腔内置入吻合金属支架应在 4 周内取出,以避免支架相关的不良反应。强烈推荐,低质量证据。